Orchestra BioMed Inc.

NASDAQ: OBIO · Real-Time Price · USD
3.32
0.27 (8.85%)
At close: Jun 06, 2025, 3:59 PM
3.31
-0.30%
After-hours: Jun 06, 2025, 04:04 PM EDT

Orchestra BioMed Revenue

Orchestra BioMed reported an annual revenue of $2.64M, reflecting a -4.42% growth. For the quarter ending March 31, 2025, Orchestra BioMed generated $868K in revenue.
Revenue (ttm)
$2.64M
Revenue Growth
-4.42%
Price / Sales Ratio
55.83
Revenue / Employee
$37.69K
Employees
70
Market Cap
127.2M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.